Viking Global is a private equity investor in Greenwich, Connecticut that targets attractive illiquid investments in early-stage companies and established businesses. It backs privately held companies across multiple funding rounds and transaction types, including primary and secondary transactions and private and public offerings, and has acted as a lead or co-lead investor in selected financings. The firm invests in the United States and Europe, with activity across healthcare and life sciences, biotechnology, medical devices, women’s health, enterprise software, data, analytics and services.